Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2515 of 5804
-
New hope for GIST patients: drug combo targets resistant tumors
Disease control Recruiting nowIn this clinical trial, the safety, tolerability, and preliminary antitumor activity of ziftomenib in combination with imatinib will be evaluated in adults with gastrointestinal stromal tumors (GIST) who have been treated previously with imatinib.
Phase: PHASE1 • Sponsor: Kura Oncology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New antibody drug takes aim at autoimmune diseases
Disease control Recruiting nowThis is an open-label, multi-ascending dose (MAD) phase 1 study, with dose expansion at selected doses, in adult patients with select autoimmune rheumatic diseases including systemic lupus erythematosus (SLE) or rheumatoid arthritis (RA). The purpose of the study is to identify p…
Phase: PHASE1 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Herbal cholesterol treatment gets a boost: higher dose tested in new trial
Disease control Recruiting nowExploring the benefit risk ratio of increase in dosage of Zhibitai capsules (2 capsules at a time, 2 times a day) compared to the original dosage (1 capsule at a time, 1 day)
Phase: PHASE2 • Sponsor: Chengdu Diao Jiuhong Pharmaceutical Factory • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Can a phone app and coach help depressed teens find joy again?
Symptom relief Recruiting nowThe study will adapt and deploy a digital Behavioral Activation app with mobile sensing, supported by health coaches, that encourages youth to engage in positive activities. The study has the potential to offer a low-cost and scalable behavioral intervention that may decrease ris…
Phase: NA • Sponsor: University of Pittsburgh • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
New gut health mix could soothe irritable bowel syndrome
Symptom relief CompletedA randomized, placebo-controlled, double-blind clinical study to evaluate the efficacy of two different mixes of HMO-2'-O-fucosyllactose (HMO-2FL) + Humiome® Post LB postbiotic (postbiotic-LB) on Gastrointestinal Symptoms in individuals with Irritable Bowel Syndrome (IBS)
Phase: NA • Sponsor: dsm-firmenich Switzerland AG • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
Simple breathing workout may cool hot flashes and improve sleep
Symptom relief Recruiting nowThe purpose of this research is to understand how training the muscles used for breathing (inhalation) affects menopausal hot flashes, sympathetic nerve activity and sleep.
Phase: NA • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC
-
Experimental cell therapy targets Hard-to-Treat prostate cancer
Disease control OngoingThis is a single-arm, single-center, open-label clinical trial designed to evaluate the clinical safety and tolerability of different doses of Prostate-Specific Membrane Antigen (PSMA)-Universal Chimeric Antigen Receptor (UCAR) T-lymphocytes (PSMA-UCAR T) for the treatment of pat…
Phase: PHASE1 • Sponsor: Shanghai Changzheng Hospital • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Mindfulness may help Low-Income latina moms lower stress and blood sugar
Symptom relief CompletedA pilot randomized control trial (RCT) to examine the efficacy of a culturally tailored mindfulness intervention upon fasting cardiometabolic factors (including markers of glycemic control) and inflammatory gene expression in n=20 (n=10 intervention, n=10 wait-list control) low-i…
Phase: NA • Sponsor: University of California, Irvine • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
New shot could replace daily pills for hypertension
Disease control OngoingThe purpose of this study is to evaluate the efficacy, safety and tolerability of QCZ484 or placebo, given subcutaneously, every 6 months, at different dose levels in patients with mild to moderate hypertension
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Can Brain-and-Body workouts help Parkinson's patients walk better?
Symptom relief Recruiting nowThe aim of this study is to examine the effects of a specialized multi-modal intervention in patients with moderate to advanced Parkinson's disease (PD). The hypothesis is that a specialized motor- and cognitive exercise program in addition to usual care can improve gait and bala…
Phase: NA • Sponsor: Annemette Lokkegaard • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
New insulin pump aims to keep blood sugar in check with fewer mealtime shots
Disease control CompletedThe goal of this multi-center, randomized, cross-over study is to evaluate the safety and effectiveness of the Omnipod 5 SmartAdjust 2.0 System in individuals with type 1 or type 2 diabetes. Study participants will complete about 5 in-person visits and be expected to treat their…
Phase: NA • Sponsor: Insulet Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New pill ONO-1110 tested for fibromyalgia pain relief
Symptom relief CompletedTo Evaluate the Efficacy and Safety of ONO-1110 in Patients with Fibromyalgia
Phase: PHASE2 • Sponsor: Ono Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Jul 09, 2026 00:00 UTC
-
Could a bladder rinse ease pain after kidney stone surgery?
Symptom relief Recruiting nowPost-operative pain and lower urinary tract symptoms are common following ureteroscopy in the treatment of stone disease. The use of bupivacaine as a topical pain medication is used routinely for other urologic procedures, however, to date there are no studies that have rigorousl…
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
Liver transplant breakthrough? albumin may shield kidneys
Disease control Recruiting nowTo verify whether albumin administration to achieve serum concentration above 30g/L (treated group) and its maintenance within plasmatic physiologic range (above 30 g/L) for five days diminishes rate of AKI at Day 7 after liver transplantation as compared to restrained albumin ad…
Phase: PHASE4 • Sponsor: Rennes University Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New eye drop combo aims to soothe dry eye sufferers
Symptom relief Recruiting nowThe goal of this clinical investigation plan is to evaluate the performance, tolerability, safety, and compliance of an ophthalmic solution containing an ancillary medicinal substance and hyaluronic acid 0.3% (FBV\_01) compared with hyaluronic acid 0.3% alone in adult men and wom…
Phase: NA • Sponsor: FB Vision S.p.A • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
Could sound waves and special insoles ease RA foot pain?
Symptom relief CompletedThis randomised controlled trial aims to investigate the effects of underwater ultrasound therapy and customised foot insoles in RA patients. The study evaluates the effects of the combined use of these two methods on pain, functional status and quality of life. The research aims…
Phase: NA • Sponsor: Kirsehir Ahi Evran Universitesi • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
MRNA cancer shots: new hope or hype?
Disease control OngoingThe purpose of this study is to assess the safety and tolerability of mRNA-4106 monotherapy and of mRNA-4200 in combination with checkpoint inhibitor therapy in participants with solid tumors.
Phase: PHASE1 • Sponsor: ModernaTX, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Brain scan study aims to solve shunt surgery mystery in elderly
Knowledge-focused Recruiting nowIdiopathic Normal Pressure Hydrocephalus (iNPH) is a progressive condition of the elderly that results in severe disability. iNPH can dramatically respond to Cerebral spinal fluid(CSF)-shunting where excess ventricular fluid is diverted from the brain. Not all patients with iNPH …
Sponsor: Imperial College London • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Massive biobank aims to predict which brain aneurysms will rupture
Knowledge-focused Recruiting nowThe purpose of the bCAN study is to create a prospective collection of multimodal data and human samples, linked to the French Intracranial Aneurysm Registry (FRAN). The aim of bCAN is to enable risk stratification of ruptured ICAs by redefining "intracranial aneurysm disease". …
Phase: NA • Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
New drug aims to restore skin color in vitiligo patients
Disease control Recruiting nowA Randomized, Double-Blind, Placebo Controlled, Multi-center Study to Evaluate the Safety and Efficacy of FB102 in Patients with Non-Segmental Vitiligo.
Phase: PHASE1 • Sponsor: Forte Biosciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC